<DOC>
	<DOCNO>NCT00183742</DOCNO>
	<brief_summary>This study patient advance cancer fail treatment conventional therapy standard treatment exist . The purpose study determine high dose give 2 chemotherapy drug , docetaxel ( also call Taxotere ) liposomal doxorubicin ( also call Doxil ) , give together determine side effect combination . Both Taxotere Doxil chemotherapy drug decrease size several different tumor . Taxotere approve Food Drug Administration ( FDA ) treatment breast lung cancer , Doxil approve treatment ovarian cancer .</brief_summary>
	<brief_title>Trial Liposomal Doxorubicin ( Doxil ) Weekly Docetaxel ( Taxotere )</brief_title>
	<detailed_description />
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Histological proof advance recurrent solid tumor fail prior therapy , effective therapy available . Ovarian cancer patient ( primary peritoneal carcinoma ) whose manifestation disease elevate cancer antigen ( CA ) 125 &gt; 100 eligible . SWOG performance status 02 . Absolute granulocyte count ( AGC ) great equal 1.5 ; platelet great equal 100,000 . Total bilirubin less equal upper limit normal ( ULN ) . Transaminases ( SGOT and/or SGPT ) may 2.5 x institutional upper limit normal ( ULN ) alkaline phosphatase &lt; = ULN , alkaline phosphatase may 4 x ULN transaminases &lt; = ULN . However , patient transaminase elevation &gt; 1.5 x ULN alkaline phosphatase &gt; 2.5 x ULN eligible study ( due decrease clearance docetaxel increase risk toxicity ) . Age great equal 18 year . Fully recover acute toxicity chemotherapy , radiation , surgery . Negative serum pregnancy test , patient female , still fertile , sexually active . Prior treatment Doxil weekly docetaxel . Prior docetaxel administer every 3 week allow . Evidence moderate peripheral neuropathy great equal grade 2 . Medical , social , psychological factor interfere compliance . Known history cardiac disease ( congestive heart failure , coronary artery disease ) would preclude treatment Doxil opinion investigator . Cardiac ejection fraction &lt; 50 % Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Phase I</keyword>
	<keyword>Phase one</keyword>
	<keyword>Solid tumor</keyword>
</DOC>